Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Biomaterials. 2015 Aug 8;70:37–47. doi: 10.1016/j.biomaterials.2015.08.014

Figure 5.

Figure 5

Biodistribution of radiolabeled Gal-APN in vivo at 4 h post i.v. injection. (A) Quantification of the liver (before and after perfusion) and blood concentrations of the Gal(14%)-APN, APN and p41 (50 μg p41 or its APN format per animal). The values in parenthesis indicate the mean liver (perfused)-to-blood ratio. (B). Tissue distribution of Gal(14%)-APN, APN and p41. Apart from liver, a higher accumulation of Gal(14%)-APN was found in lung and kidney. All results were interpreted as mean percentage of injected dose per gram of tissue (%ID/g) ± SEM (n = 6); *p < 0.05, **p < 0.01, ***p < 0.001, NS - not significant.